• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细菌 DNA 易位与肝硬化患者全身循环异常和肝内内皮功能障碍有关。

Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis.

机构信息

Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

出版信息

Hepatology. 2010 Dec;52(6):2044-52. doi: 10.1002/hep.23918. Epub 2010 Oct 26.

DOI:10.1002/hep.23918
PMID:20979050
Abstract

UNLABELLED

Presence of bacterial DNA in noninfected patients with cirrhosis and ascites is associated with a marked inflammatory response including activation of the inducible form of nitric oxide synthase and release of nitric oxide, similar to that observed in patients with spontaneous bacterial peritonitis. Although presence of bacterial DNA is associated with an impaired prognosis, no information is available regarding its hemodynamic consequences. Systemic and hepatic hemodynamics before and after a liquid test meal were assessed in a series of 75 noninfected patients with cirrhosis (55 with ascites). Bacterial DNA was measured by polymerase chain reaction. Bacterial DNA was detected only in patients with ascites. Clinical data and liver function were similar in ascitic patients with presence (n = 21) or absence of bacterial DNA (n = 34). Bacterial-DNA(+) patients had significantly lower mean arterial pressure (P = 0.002) and systemic vascular resistance (P = 0.03) than bacterial-DNA(-) patients. Cardiac output, cardiopulmonary pressures, hepatic venous pressure gradient (HVPG), and hepatic blood flow were similar in both groups. Thirty minutes after the test meal, in response to increased blood flow caused by postprandial hyperemia, there was a significantly greater increase in HVPG and impaired hepatic vasorelaxation in bacterial-DNA(+) as compared with bacterial-DNA(-) patients, which indicates hepatic endothelial dysfunction. Indeed, the increase in HVPG after the test meal significantly correlated with serum bacterial DNA concentration.

CONCLUSION

Presence of bacterial DNA, a marker of bacterial translocation, is associated with aggravation of peripheral vasodilation and with worsening of intrahepatic endothelial dysfunction.

摘要

未注明

在非感染性肝硬化伴腹水患者中存在细菌 DNA 与明显的炎症反应有关,包括诱导型一氧化氮合酶的激活和一氧化氮的释放,类似于自发性细菌性腹膜炎患者。虽然存在细菌 DNA 与预后不良有关,但关于其血流动力学后果尚无信息。在一系列 75 例非感染性肝硬化患者(55 例伴腹水)中,评估了液体试验餐后的全身和肝血流动力学。通过聚合酶链反应测量细菌 DNA。仅在有腹水的肝硬化患者中检测到细菌 DNA。腹水患者中存在(n = 21)或不存在细菌 DNA(n = 34)的临床数据和肝功能相似。细菌 DNA(+)患者的平均动脉压(P = 0.002)和全身血管阻力(P = 0.03)明显低于细菌 DNA(-)患者。两组心输出量、心肺压力、肝静脉压力梯度(HVPG)和肝血流量相似。试验餐后 30 分钟,由于餐后充血引起的血流量增加,细菌 DNA(+)患者的 HVPG 显著增加,肝血管舒张受损,与细菌 DNA(-)患者相比,这表明肝内皮功能障碍。事实上,试验餐后 HVPG 的增加与血清细菌 DNA 浓度显著相关。

结论

细菌 DNA 的存在,细菌易位的标志物,与外周血管舒张恶化和肝内内皮功能障碍恶化有关。

相似文献

1
Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis.细菌 DNA 易位与肝硬化患者全身循环异常和肝内内皮功能障碍有关。
Hepatology. 2010 Dec;52(6):2044-52. doi: 10.1002/hep.23918. Epub 2010 Oct 26.
2
Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites.口服益生菌VSL#3可减轻肝硬化腹水患者的循环系统紊乱。
Liver Int. 2014 Nov;34(10):1504-12. doi: 10.1111/liv.12539. Epub 2014 Apr 4.
3
Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension.抗坏血酸可改善肝硬化和门静脉高压症患者的肝内内皮功能障碍。
Hepatology. 2006 Mar;43(3):485-91. doi: 10.1002/hep.21080.
4
Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis.肝硬化和非感染性腹水患者体内的细菌DNA模拟了自发性细菌性腹膜炎患者建立的可溶性免疫反应。
Hepatology. 2008 Mar;47(3):978-85. doi: 10.1002/hep.22083.
5
LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.超声心动图评估肝硬化患者左心室功能:与全身血液动力学和肾功能障碍的关系。
J Hepatol. 2013 Jan;58(1):51-7. doi: 10.1016/j.jhep.2012.08.027. Epub 2012 Sep 16.
6
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.肝硬化合并自发性细菌性腹膜炎患者的全身、肾脏和肝脏血流动力学紊乱
Hepatology. 2003 Nov;38(5):1210-8. doi: 10.1053/jhep.2003.50447.
7
Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.静脉输注白蛋白对肝硬化合并自发性细菌性腹膜炎患者全身及肝脏血流动力学和血管活性神经激素系统的影响。
J Hepatol. 2004 Sep;41(3):384-90. doi: 10.1016/j.jhep.2004.05.009.
8
Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study.在肝硬化患者的血清和腹水中出现细菌 DNA 之前,肠道功能已经发生改变:一项初步研究。
Eur J Gastroenterol Hepatol. 2010 Oct;22(10):1228-34. doi: 10.1097/MEG.0b013e32833b4b03.
9
Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.
Gastroenterology. 2004 Mar;126(3):749-55. doi: 10.1053/j.gastro.2003.12.007.
10
Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.生长抑素对肝硬化患者肝脏及全身血流动力学的影响:与血管加压素的比较。
Gastroenterology. 1981 Mar;80(3):518-25.

引用本文的文献

1
Role of Intestinal Microbiome in Potentiating Inflammation and Predicting Outcomes in Alcohol-Associated Cirrhosis.肠道微生物群在增强酒精性肝硬化炎症及预测预后中的作用
Gastroenterol Clin North Am. 2025 Jun;54(2):453-467. doi: 10.1016/j.gtc.2024.12.001. Epub 2025 Jan 18.
2
The interplay between lymphatic system and portal hypertension: a comprehensive review.淋巴系统与门静脉高压之间的相互作用:综述
Hepatol Int. 2025 Apr 3. doi: 10.1007/s12072-025-10815-5.
3
Cirrhosis and Faecal microbiota Transplantation (ChiFT) protocol: a Danish multicentre, randomised, placebo-controlled trial in patients with decompensated liver cirrhosis.
肝硬化与粪便微生物群移植(ChiFT)方案:一项针对失代偿期肝硬化患者的丹麦多中心、随机、安慰剂对照试验。
BMJ Open. 2025 Feb 12;15(2):e091078. doi: 10.1136/bmjopen-2024-091078.
4
Development and validation of a machine learning-based prediction model for hepatorenal syndrome in liver cirrhosis patients using MIMIC-IV and eICU databases.使用MIMIC-IV和eICU数据库开发并验证基于机器学习的肝硬化患者肝肾综合征预测模型
Sci Rep. 2025 Jan 22;15(1):2743. doi: 10.1038/s41598-025-86674-9.
5
Inflammation remains a dynamic component of portal hypertension in regressive alcohol-related cirrhosis.在酒精性退行性肝硬化中,炎症仍然是门静脉高压的一个动态组成部分。
United European Gastroenterol J. 2025 Apr;13(3):317-329. doi: 10.1002/ueg2.12643. Epub 2024 Dec 21.
6
Mechanisms and implications of recompensation in cirrhosis.肝硬化再代偿的机制及意义
JHEP Rep. 2024 Oct 10;6(12):101233. doi: 10.1016/j.jhepr.2024.101233. eCollection 2024 Dec.
7
Nanomechanical detection to empower robust monitoring of sepsis and microbial adaptive immune system-mediated proinflammatory disease.纳米机械检测助力对败血症和微生物适应性免疫系统介导的促炎性疾病进行强有力的监测。
Sci Rep. 2024 Dec 2;14(1):29979. doi: 10.1038/s41598-024-80126-6.
8
Liver Cirrhosis: The Immunocompromised State.肝硬化:免疫功能低下状态。
J Clin Med. 2024 Sep 20;13(18):5582. doi: 10.3390/jcm13185582.
9
Clinical Implications of Inflammation in Patients With Cirrhosis.肝硬化患者炎症的临床意义
Am J Gastroenterol. 2025 Jan 1;120(1):65-74. doi: 10.14309/ajg.0000000000003056. Epub 2024 Aug 27.
10
Gut-bacteria derived membrane vesicles and host metabolic health: a narrative review.肠道细菌衍生的膜泡与宿主代谢健康:叙述性综述。
Gut Microbes. 2024 Jan-Dec;16(1):2359515. doi: 10.1080/19490976.2024.2359515. Epub 2024 May 29.